Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 1227158-72-6
Drug Levels and Effects
Summary of Use during Lactation
Conbercept is not approved for marketing in the United States by the U.S. Food and Drug Administration. Conbercept is a large protein molecule that inhibits vascular endothelial growth factor (VEGF). Amounts in milk after intravitreal injection is likely to be low and absorption by the infant is unlikely because it is probably partly destroyed in the infant's gastrointestinal tract and poorly absorbed orally, so systemic effects in infants are not expected. Since VEGF is present in human milk and is thought to help in maturation of the infant’s gastrointestinal tract, concern has been raised about the maternal use of VEGF inhibitors during breastfeeding.[1] However, only 1 of 3 mothers given conbercept had a small decrease in milk VEGF levels and it rebounded in a few days. Furthermore, the typical alternative to breastmilk is infant formula, which contains no VEGF.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Three women were given intravitreal injections of conbercept 0.05 mg in one eye to treat choroidal neovascularization. VEGF levels were measured in breastmilk after one injection. Two of the women had no decrease in breastmilk VEGF. The third woman had a decrease in her milk VEGF level on day 7 after the injection, from 1.72 ng/mL to 1.42 ng/mL, a decrease of 15%. Over the following 3 weeks, the VEGF level increased to the baseline value.[2]
Alternate Drugs to Consider
(Intravitreal) Aflibercept, Bevacizumab, Ranibizumab
References
- 1.
- Dalal PJ, Patel AL, Carle M, et al. Review of ophthalmic and breastfeeding medicine evidence: Real and theoretical risks of intravitreal anti-VEGF administration in lactating women. Retina. 2020;40:2065–9. [PubMed: 32796446]
- 2.
- Shao Z, Li S, Yu X, et al. Intravitreal conbercept for idiopathic choroidal neovascularization in nursing women. Breastfeed Med. 2021;16:915–8. [PubMed: 34213377]
Substance Identification
Substance Name
Conbercept
CAS Registry Number
1227158-72-6
Drug Class
Breast Feeding
Lactation
Angiogenesis Inhibitors
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubMedLinks to PubMed
- Review Aflibercept.[Drugs and Lactation Database (...]Review Aflibercept.. Drugs and Lactation Database (LactMed®). 2006
- Review Ranibizumab.[Drugs and Lactation Database (...]Review Ranibizumab.. Drugs and Lactation Database (LactMed®). 2006
- Review Brolucizumab.[Drugs and Lactation Database (...]Review Brolucizumab.. Drugs and Lactation Database (LactMed®). 2006
- Review Ziv-Aflibercept.[Drugs and Lactation Database (...]Review Ziv-Aflibercept.. Drugs and Lactation Database (LactMed®). 2006
- Review Faricimab.[Drugs and Lactation Database (...]Review Faricimab.. Drugs and Lactation Database (LactMed®). 2006
- Conbercept - Drugs and Lactation Database (LactMed®)Conbercept - Drugs and Lactation Database (LactMed®)
- pantetheine-phosphate adenylyltransferase [Cloacibacillus porcorum]pantetheine-phosphate adenylyltransferase [Cloacibacillus porcorum]gi|1050316984|gnl|PRJNA335387|BED41 5|gb|ANZ44703.1|Protein
Your browsing activity is empty.
Activity recording is turned off.
See more...